Supply Chain

After collecting 21,000 fewer donations than hospitals needed, the American Red Cross is facing a severe blood shortage, according to The Herald News.

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

Boston Scientific, a medical devicemaker, plans to shed $150 million in expenses annually over the next three years, which may include "limited" layoffs, according to the Boston Business Journal.

We recently surveyed more than 400 hospital staff, including nurses, physicians, service line leaders and supply chain administrators, to understand how the supply chain affected their day-to-day work. We learned that these colleagues shared some fundamental goals, but each held…

Here are four drugs or medical devices that have been approved by the FDA since Nov. 9:

Seventy-three percent of hospital leaders consider value-based contracting with suppliers a priority for improving return on investment, but opportunities for these types of contracts lag, according to a recent Premier survey.

Software issues continued to drive medical device recalls during the third quarter of 2018, reflecting the growing popularity of internet-connected products, according to a recent analysis of U.S. recall data.

The Red Cross announced Nov. 13 it received 21,000 fewer blood donations in the months of September and October than it needed.

The FDA's policies and procedures don't sufficiently outline how to respond to cybersecurity risks for medical devices in the postmarket phase, according to a report from the HHS Office of Inspector General.

Some smartphones from Samsung Electronics may soon offer users with diabetes access to an insulin pump delivery system, thanks to a collaboration with insulin pump manufacturer Insulet Corp.